Members

In this section

Thank you, 2026 Industry Roundtable members.

The Âé¶¹´«Ã½Ó³»­ and the Industry Roundtable collaborate on opportunities to support neurology and serve patients with neurological disease.

$75,000 members

   


$50,000 members

Bayer logoHarmony Biosciences logoIspen Biopharmaceuticals logoSupernus_250x158_2022.png


$25,000 members

  • Alnylam Pharmaceuticals, Inc.
  • Amneal Specialty, a division of Amneal Pharmaceuticals LLC
  • Annexon Biosciences
  • AstraZeneca
  • Bristol Myers Squibb
  • C2N Diagnostics
  • Immunovant
  • Ionis Pharmaceuticals
  • Johnson & Johnson
  • Neurocrine Biosciences
  • Octapharma
  • Praxis Precision Medicines, Inc.
  • Roche
  • Sandoz
  • The Global CEO Initiative on Alzheimer's Disease
  • Xenon Pharmaceuticals

$10,000 members

  • Alkermes
  • Avidity Biosciences
  • Cognito Therapeutics
  • Dianthus Therapeutics
  • ITF Therapeutics
  • Kyverna Therapeutics
  • Stoke Therapeutics
  • Vor Biopharma

All grants, sponsorships, and IRT memberships must comply with the Âé¶¹´«Ã½Ó³»­’s Principles Governing Academy Relationships with External Sources of Support, the Accreditation Council for Continuing Medical Âé¶¹´«Ã½Ó³»­ (ACCME) Standards for Commercial Support, and the Council of Medical Specialty Societies’ Code for Interactions with Companies. Âé¶¹´«Ã½Ó³»­ accepts financial and in-kind support from corporations, foundations, individuals, and other organizations only if such acceptance would not pose a conflict of interest and in no way impair the Âé¶¹´«Ã½Ó³»­’s objectivity, influence, priorities, and actions. Support of Âé¶¹´«Ã½Ó³»­ programs or participation on the IRT does not permit influence over content, nor does it imply Âé¶¹´«Ã½Ó³»­ approval or endorsement of an organization’s policies or products.